DR. CHERYL DEWAN BANSAL M.D. NPI 1174790851

NPI Details

DR. Cheryl Dewan Bansal, M.D. is a specialist in Columbia, MD with 18 years of experience. The provider is an individual educated and trained in an applied knowledge discipline used in the performance of work at a level requiring knowledge and skills beyond or apart from that provided by a general education or liberal arts degree. DR. Cheryl Dewan Bansal, M.D. NPI is 1174790851. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a female.

Education
Medical School: HAHNEMANN UNIVERSITY COLLEGE OF MEDICINE
Graduation Year:2007

The provider's business location address is:

9256 BENDIX RD STE 200A
COLUMBIA, MD
ZIP 21045-848
Phone: (443) 542-0505
Fax: (443) 542-0506

The NPI 1174790851 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

• Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
• Destruction of precancer skin growth, 2-14 growths (HCPCS:17003)
• Therapy procedure using ultraviolet radiation with tar or petroleum jelly application (HCPCS:96910)
• Destruction of precancer skin growth, 1 growth (HCPCS:17000)
• Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
• Destruction of skin growth, 1-14 growths (HCPCS:17110)
• Injection, triamcinolone acetonide, not otherwise specified, 10 mg (HCPCS:J3301)
• Biopsy of related skin growth, first growth (HCPCS:11102)
• New patient office or other outpatient visit, 30-44 minutes (HCPCS:99203)
• Aminolevulinic acid hcl for topical administration, 20%, single unit dosage form (354 mg) (HCPCS:J7308)
• Application of light with debridement to destroy precancer skin growth (HCPCS:96574)
• New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)
• Injection of drug or substance under skin or into muscle (HCPCS:96372)
• Biopsy of related skin growth, each additional growth (HCPCS:11103)
• Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm (HCPCS:12032)
• Removal of cancer skin growth of body, arms, or legs, 2.1-3.0 cm (HCPCS:11603)
• Destruction of precancer skin growth, 15 or more growths (HCPCS:17004)
• Complicated repair of wound of trunk, 2.6-7.5 cm (HCPCS:13101)
• Removal of cancer skin growth of body, arms, or legs, 1.1-2.0 cm (HCPCS:11602)
• Acne surgery (HCPCS:10040)
• Simple or single drainage of skin abscess (HCPCS:10060)
• Melanoma (skin cancer) excision (HCPCS:NAN03)

The enumeration date for this NPI number is 5/13/2008 and was last updated on 6/29/2023.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

Other Identifiers

The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.